Related Experiment Video

Updated: Dec 29, 2025

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.1K

[Clinical research of circulating tumor DNA: progress and prospect]

H Q Jiang1, W Guo1

  • 1Department of Clinical Laboratory, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Zhonghua Yi Xue Za Zhi
|February 3, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.6K
Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
07:47

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Published on: December 25, 2021

4.5K

Related Experiment Videos

Last Updated: Dec 29, 2025

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.1K
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.6K
Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
07:47

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Published on: December 25, 2021

4.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K

Articles linked to this work by shared authors, journal, and citation graph.

[Establishment of reference intervals for plasma p-tau181, Aβ1-42, Aβ1-40, and Aβ1-42/40 ratio and a preliminary study of their correlation with corresponding cerebrospinal fluid reference intervals].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026

[Cerebellar hemangioblastoma presenting with positional vertigo as the initial symptom: a case report and literature review].

Zhonghua yi xue za zhi·2025

[Association between diabetes prevalence and mortality risk in the elderly aged 60 years and above in Liaoning Province, 2017-2019].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2024

Corrigendum: Use of autologous cord blood mononuclear cells infusion for the prevention of bronchopulmonary dysplasia in extremely preterm neonates: a study protocol for a placebo-controlled randomized multicenter trial [NCT03053076].

Frontiers in pediatrics·2023

[Y-box-binding protein 1 mediates sorafenib resistance via the extracellular signal regulated-protein kinase pathway in hepatoma cells].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2023

[Analysis of influencing factors of KRAS/NRAS/BRAF/PIK3CA gene mutation consistency in patients with advanced colorectal cancer].

Zhonghua yi xue za zhi·2021

[From PCOS to PMOS: nomenclature revision and paradigm shift in disease perception].

Zhonghua yi xue za zhi·2026

[Analysis of risk factors for central diabetes insipidus in Langerhans cell histiocytosis].

Zhonghua yi xue za zhi·2026

[Neuroimaging features of white matter lesions related to patent foramen ovale].

Zhonghua yi xue za zhi·2026

[Effect and mechanism of chloroquine on supressing the growth of pancreatic neuroendocrine tumors].

Zhonghua yi xue za zhi·2026

[Development of a prediction model for acute heart failure based on B-type natriuretic peptide and multiple clinical indicators in acute dyspnea patients with varying renal function levels].

Zhonghua yi xue za zhi·2026

[Screening efficacy of different evaluation indicators of peak expiratory flow for chronic obstructive pulmonary disease and the assessment efficacy of the severity of airflow limitation].

Zhonghua yi xue za zhi·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us